Merck (MRK) Interest Expenses (2011 - 2013)

Merck (MRK) has 3 years of Interest Expenses data on file, last reported at $184.0 million in Q1 2013.

• Quarterly Interest Expenses rose 5.14% year-over-year to $184.0 million in Q1 2013, while the trailing twelve-month figure through Dec 2013 was $184.0 million (down 74.27% YoY) and the FY2012 annual result came in at $714.0 million, up 2.73% from the prior year.
• Interest Expenses fell to $184.0 million in Q1 2013 per MRK's latest filing, from $190.0 million in the prior quarter.
• Across five years, Interest Expenses topped out at $190.0 million in Q4 2012 and bottomed at $170.0 million in Q2 2011.
• The 3-year median for Interest Expenses is $176.0 million (2011), against an average of $178.2 million.
• Peak annual rise in Interest Expenses reached 9.83% in 2012, while the deepest fall reached 5.91% in 2012.
• Tracing MRK's Interest Expenses over 3 years: stood at $173.0 million in 2011, then gained by 9.83% to $190.0 million in 2012, then decreased by 3.16% to $184.0 million in 2013.
• Per Business Quant, the three latest MRK Interest Expenses figures stand at $184.0 million (Q1 2013), $190.0 million (Q4 2012), and $178.0 million (Q3 2012).

Peer Comparison